Your browser doesn't support javascript.
loading
Adherence to migraine treatment does not depend on the number of prescribed medications / A adesão ao tratamento da migrânea não depende do número de medicações prescritas
Arquivos de Neuro-Psiquiatria; Dozza, Ana Luísa C. Brasil; Krymchantowski, Abouch Valenty.
Affiliation
  • Dozza, Ana Luísa C. Brasil; Neurologist, MD, Universidade Federal Fluminense (UFF). Niterói. BR
  • Krymchantowski, Abouch Valenty; Neurologist, MD, Universidade Federal Fluminense (UFF). Niterói. BR
Arq. neuropsiquiatr ; 71(3): 171-173, mar. 2013. tab, graf
Article in En | LILACS | ID: lil-668763
Responsible library: BR1.1
ABSTRACT
Objective To compare the adherence between monotherapy and politherapy in prophylactic migraine treatment. <a class="decs" id="008901">Method</a> Five hundred consecutive patients with migraine from a tertiary center were retrospectively studied as to the number of preventive medications prescribed during the first visit. Adherence, defined as returning for the next consultation after 4 to 6 weeks and following the prescribed regimens, were also evaluated and compared between patients. Results 71.8% were women, and 6% of the patients did not receive any preventive medication, 11.4% received one drug, 22.2% two drugs, 41.4% three drugs, and 19% four drugs for the prevention of migraine. The overall adherence was 79.6%. Respectively, 73.7, 71.8, 82.6 and 86.3% of those who received the prescription of one, two, three and four drugs returned, complying with the treatment. Conclusion There is no difference in adherence to monotherapy or politherapy (one to four drugs) for the prophylaxis of migraine. .
RESUMO
Objetivo Comparar a adesão entre monoterapia e politerapia no tratamento profilático da migrânea. <a class="decs" id="008901">Método</a> Foram analisados retrospec-tivamente 500 pacientes com migrânea de um centro terciário, com vistas ao número de medicações preventivas prescritas na primeira consulta e adesão ao tratamento após 4 a 6 semanas. Resultados 71,8% da amostra era composta de mulheres. Em relação ao tratamento preventivo da migrânea, 6% não receberam medicação preventiva; 11,4% receberam uma droga; 22,2% duas drogas; 41,4% três drogas e 19% quatro drogas. A adesão média foi de 79,6%. Em relação à prescrição de uma, duas, três ou quatro drogas, essa adesão foi respectiva-mente de 73,7, 71,8, 82,6 e 86,3%. Conclusão Não houve diferenças na adesão à prescrição de medicações em monoterapia ou politerapia (uma a quatro drogas) para o tratamento preventivo da migrânea. .
Subject(s)
Key words

Full text: 1 Index: LILACS Main subject: Prescription Drugs / Medication Adherence / Migraine Disorders Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male Country/Region as subject: America do sul / Brasil Language: En Journal: Arq. neuropsiquiatr Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 2013 Type: Article

Full text: 1 Index: LILACS Main subject: Prescription Drugs / Medication Adherence / Migraine Disorders Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male Country/Region as subject: America do sul / Brasil Language: En Journal: Arq. neuropsiquiatr Journal subject: NEUROLOGIA / PSIQUIATRIA Year: 2013 Type: Article